Peptide Library / Detail
Cerebrolysin
Half-life
2-4 hours
Delivery
Intravenous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
Cerebrolysin is a porcine brain-derived peptide preparation containing a mixture of low molecular weight neuropeptides and amino acids. It has been used clinically in Europe and Asia for several decades as a nootropic and neuroprotective agent. The complex mimics the action of endogenous neurotrophic factors and is primarily researched for cognitive enhancement and neurological recovery.
Usage
Typical research protocols involve intravenous or intramuscular administration at doses ranging from 5-30 mL per session, administered 5 days per week for 4 weeks, followed by a pause period. Treatment cycles are often repeated for chronic conditions. Dosing frequency and duration vary based on the specific indication being studied.
Mechanism of Action
Cerebrolysin acts through multiple pathways including neurotrophic factor-like activity, promoting neuronal survival and differentiation. It modulates excitatory neurotransmission, provides antioxidant effects, protects against apoptosis, and enhances synaptic plasticity. The peptide complex supports neurogenesis and may improve glucose metabolism in brain tissue.
Benefits(6)
- Enhanced cognitive function and memory
- Neuroprotective effects in stroke and traumatic brain injury
- Potential improvement in neurodegenerative disease progression
- Increased neuroplasticity and neuronal survival
- Improved attention and mental processing speed
- Support for functional recovery after neurological damage
Side Effects(7)
- Injection site reactions or discomfort
- Headache
- Dizziness or vertigo
- Agitation or restlessness
- Hyperactivity in some individuals
- Rare allergic reactions
- Potential increases in blood pressure